Yes, the phase three study was implemented. It began in September in Pakistan and Russia. Pakistan enrolled a large number of participants and then enrolment was started in Mexico, Chile and Argentina. Pakistan and Mexico were the two countries that contributed the most participants, volunteers, to the study. It underwent an interim analysis, the same type of analysis that was done by the Pfizer vaccine that received a lot of press. Pfizer vaccine's interim analysis was in December. CanSino's was at the end of January, and it was reported to have an efficacy of over 70%. Based on those results, it received emergency authorization in Pakistan and Mexico. There are multiple other countries where that emergency authorization is also being reviewed by their regulators. That vaccine is now being used in those countries under emergency authorization.
